Table 9: Summary of Participant Demographic Characteristics of Included Studies.
| Study, N | Sex: Female (%) | Age (years)* | Ethnicity (%) | Duration of Diabetes (years)* | BMI (kg/m2)* | Baseline HbA1c (%)* | Baseline SBP (mm Hg)* | Total Cholesterol* | HDL Cholesterol* | Smoker Status (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| MODEL OF CARE: 1. At least a registered nurse, registered dietician and physician (primary care and/or specialist) | ||||||||||
|
California Medi-Cal Diabetes Study Group, 2004 (14) N = 335 |
Intervention: 72.6 Control: 70.9 |
Intervention: 57.0 ± 0.9 Control: 56.9 ± 1.0 |
Intervention: African-Am:16.1 Hispanic: 39.2 Caucasian: 34.9 Other: 9.7 Control: African-Am: 15.7 Hispanic: 38.4 Caucasian: 36.0 Other: 9.9 |
Intervention: 10.3±0.8 Control: 12.0±0.8 |
Intervention: 33.1±0.8 Control: 31.5±0.8 |
Mean ± SE: Intervention:9.6±0.1 Control:9.7±0.1 |
Mean ± SE: Intervention: 136 ± 2 Control: 134 ± 1 |
Mean ± SE: Intervention: 210.0±3.3 mg/dl Control: 212.1±3.7 mg/dl |
Mean ± SE: Intervention:41.9 ± 1.0 mg/dl Control:43.0 ± 1.1 mg/dl |
Intervention: 14.8 Control: 13.0 |
|
Gaede, et al, 2001 (13) N = 149 |
NR | 55.1 ± 7.2 | NR | Median (IQR): 6 (4-10) | NR | Intervention: 8.4±1.5 Control: 8.8±1.7 |
NR | Intervention: 5.4±1.0 mmol/L Control: 5.8±1.3 mmol/L |
Intervention: 1.03±0.2 mmol/L Control: 1.01±0.3 mmol/L |
Intervention: 38.4 Control: 34.2 |
|
Groeneveld, et al, 2001 (16) N = 246 |
Intervention: 65.9 Control: 53.5 |
Intervention: 62.7 ± 11 Control: 62.3 ± 10 |
NR | Intervention: 4.1 ± 3.7 Control: 4.6 ± 4.0 |
NR | NA | Intervention: 137±27 Control: 149±24 |
Intervention:6.2 ± 1.2 mmol/L Control:6.2 ± 1.3 mmol/L |
NR | NR |
|
Johansen, et al, 2007 (15) N = 106 |
Intervention: 28 Control: 23 |
Intervention: 59 ± 9 Control: 58 ± 11 |
NR | Median (IQR): Intervention: 4 (1-10) Control: 3 (1-12) |
Median (min, max): Intervention: 30.6 (22.6, 484) Control: 28.6 (16.1, 42.3) |
Intervention:7.5± 1.5 Control:7.6± 1.6 |
Intervention: 136 ± 16 Control: 130 ± 13 |
Intervention:5.0 ± 1.0 mmol/L Control:5.0 ± 0.9 mmol/L |
Intervention:1.3 ± 0.4 mmol/L Control:1.3 ± 0.4 mmol/L |
Intervention: 8 Control: 15 |
|
Maislos, et al, 2004 (12) N = 82 |
Intervention: 50 Control: 65 |
Intervention: 58 ± 14 Control: 63 ± 9 |
NR | NR | Intervention: 30.8 ± 3.6 Control: 30.8 ± 3.0 |
Intervention: 12.9 ± 3.4 Control: 12.6 ± 2.9 |
NR | NR | NR | NR |
|
Choe, et al, 2005 (22) N = 80 |
Intervention: 51.2 Control: 53.9 |
Intervention: 52.2 ± 11.2 Control: 51.0 ± 9.0 |
Intervention: African-Am: 17.1 Caucasian: 80.5 Other: 2.4 Control: African-Am: 12.8 Caucasian: 71.8 Other: 5.1 Unknown: 10.3 |
NR | NR | Intervention:10.1± 1.8 Control:10.2± 1.7 |
NR | NR | NR | NR |
|
McLean, et al, 2008 (18) N = 227 |
Intervention: 34.8 Control: 65.5 |
Intervention: 66.2 ± 11.3 Control: 63.7 ± 12.7 |
NR | NR | Intervention: 31.7 ± 6.0 Control: 31.6 ± 7.9 |
NR | Intervention: 142.5 ± 15.5 Control: 139.9 ± 11.9 |
NR | NR | Intervention: 9.6 Control: 10.77 |
|
Rothman, et al, 2005 (17) N = 217 |
Intervention: 56 Control: 56 |
Intervention: 54 ± 13 Control: 57 ± 11 |
Intervention: African-Am: 70 Control: African-Am: 59 |
Intervention:8 ± 9 Control: 9 ± 9 |
Intervention: 35 ± 9 Control: 34 ± 8 |
Intervention: 10.8 ± 2.1 Control: 10.7 ± 2.5 |
Intervention: 141.2 ± 21.8 Control: 137.4 ± 21.2 |
Intervention:217.0± 86.5 mg/dl Control:207.1± 64.1 mg/dl |
NR | NR |
*
All values summarized as mean ± SD unless otherwise specified